Skip to main content

Nepal: Coronavirus

Question for Foreign, Commonwealth and Development Office

UIN 29796, tabled on 8 July 2021

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps he is planning to take in response to the situation in Nepal where 1.4 million vulnerable people require AstraZeneca covid-19 vaccines in the next seven days before the timeframe elapses for a second dose.

Answered on

16 July 2021

The UK is a leading donor to COVAX, the multilateral mechanism set up to support international co-operation on vaccines, having committed £548 million to the scheme. COVAX has delivered 348,000 doses to Nepal so far with further tranches on the way. As G7 chair this year the UK has also secured a commitment to donate 1 billion vaccine doses to the developing world by June 2022, including 100 million donated by the UK - the first 5 million in the coming weeks. The majority of these doses will be donated to COVAX. COVAX remains best-placed to allocate vaccines to where they will be most effective. It is helping to support countries to assess vaccine introduction readiness, develop detailed national deployment and vaccination plans, and strengthen delivery systems. As shareholders and contributors to both the World Bank and the Asian Development Bank, the UK has also pushed hard for multilateral organisations to provide finance to countries for vaccine procurement, including Nepal. The World Bank has now made at least $75 million available to the Government of Nepal for that purpose; a further $165 million will soon be proposed to the board of the Asian Development Bank, which the UK will also support.